BioCentury
ARTICLE | Clinical News

Fluticasone propionate/salmeterol regulatory update

July 11, 2016 7:00 AM UTC

FDA accepted for review NDAs from Teva for fluticasone propionate and fluticasone propionate/salmeterol delivered via the RespiClick breath-actuated, multidose dry powder inhaler (MDPI) to treat asthm...